Challenges Facing The Life Science Private Equity Space [Forbes]
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: Forbes
The mathematical imperative for private equity is simple: Deliver roughly three times invested capital over a three- to five-year hold period. To do this, companies generally need to use three main drivers: 1. Topline growth 2. Margin expansion (or operational leverage) 3. Multiple expansion (the exit multiple/valuation multiple growing relative to entry) In many buyouts over the past decade, the multiple expansion leg has been an easy driver because public market valuation multiples steadily climbed. For example, the Shiller P/E ratio—which investors use to assess market valuations —has increased from around 25 in 2014 to almost 40 today , providing many companies with a valuation boost with little effort. The effect is even more pronounced when you consider that P/E ratios today are artificially lower because of the 2017 tax cuts, which dropped corporate tax rates from 35% to 21% . Lower taxes mean increased earnings, as more dollars drop to the bottom line and artificially
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Morgan Stanley Analyst Is Bullish On Thermo Fisher Scientific Inc. (TMO) [Yahoo! Finance]Yahoo! Finance
- Autoimmune Disease Diagnosis Market to Surge to USD 8.98 Billion by 2031 [Yahoo! Finance]Yahoo! Finance
- Global Molecular Cytogenetics Market Set to Reach USD 1.43 Billion by 2030 | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher Scientific (NYSE:TMO) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.MarketBeat
- Thermo Fisher Scientific (NYSE:TMO) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.MarketBeat
TMO
Earnings
- 10/22/25 - Beat
TMO
Sec Filings
- 12/11/25 - Form 4
- 12/8/25 - Form CERT
- 12/8/25 - Form CERT
- TMO's page on the SEC website